newsfilter
← Latest News
GlobeNewswire·

Humacyte To Participate in Upcoming Investor Conferences

DURHAM, N.C., March 02, 2026 (GLOBE NEWSWIRE) -- Humacyte, Inc. (NASDAQ:HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale,